Serious Event

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event

Ignite Creation Date: 2025-12-24 @ 1:53 PM
Ignite Modification Date: 2025-12-25 @ 12:43 PM
NCT ID: NCT02349295
Term: Cholelithiasis
Organ System: Hepatobiliary disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 22.0
Notes: None
Study: NCT02349295
Study Brief: A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 0 0 123 View
EG001 0 0 122 View
EG002 0 0 118 View
EG003 0 0 17 View
EG004 0 0 15 View
EG005 0 0 16 View
EG006 0 0 16 View
EG007 0 0 107 View
EG008 0 0 111 View
EG009 0 0 46 View
EG010 1 1 46 View
EG011 0 0 142 View
EG012 0 0 145 View
EG013 0 0 17 View